Abstract LB040: MACO-355, a unique pan-LILR monoclonal antibody for cancer therapy, re-programs and stimulates immuno-suppressive macrophages in a novel ligand-binding blocking independent manner

Authors: Krzysztof B. Wicher, Moritz Haneklaus, Martha Lopez-Yrigoyen, Alicia Poindron, Carmen Rodriguez-Seoane, Maikel Fransen, Chantell Payton, Stephane M. Guillame, Luca Cassetta, Stephen Myatt, Carola Ries

Published: 2024-04-05

DOI: 10.1158/1538-7445.am2024-lb040

Source: Full article